The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles

Verena M. Straub,Benjamin Barti,Sebastian T. Tandar,A. Floor Stevens,Tom van der Wel,Na Zhu,Joel Ruegger,Cas van der Horst,Laura H. Heitman,Yulong Li,Nephi Stella,J.G. Coen van Hasselt,Istvan Katona,Mario van der Stelt
DOI: https://doi.org/10.1101/2024.09.23.614520
2024-09-24
Abstract:While it is known that endocannabinoids (eCB) modulate multiple neuronal functions, the molecular mechanism governing their release and transport remains elusive. Here, we propose an 'on-demand release' model, wherein the formation of microvesicles, a specific group of extracellular vesicles (EVs) containing the eCB, 2-arachidonoylglycerol (2-AG), is the rate-limiting step. A co-culture model system that combines a reporter cell line expressing the fluorescent eCB sensor, GRABeCB2.0, and neuronal cells revealed that neurons release EVs containing 2-AG, but not anandamide, in a stimulus-dependent process regulated by PKC, DAGL, Arf6, and which was sensitive to inhibitors of eCB facilitated diffusion. A vesicle contained approximately 2000 2-AG molecules. Accordingly, hippocampal eCB-mediated synaptic plasticity was modulated by Arf6 and transport inhibitors. This 'on demand release' model, supported by mathematical analysis, offers a cohesive framework for understanding eCB signaling at the molecular level and suggests that microvesicles carrying signaling lipids regulate neuronal functions in parallel to canonical synaptic vesicles.
Neuroscience
What problem does this paper attempt to address?
This paper attempts to address the question of how endocannabinoids (eCB) are released and transported from neurons. Specifically, the paper proposes an "on-demand release" model, where the formation of extracellular microvesicles (EVs) containing 2-arachidonoylglycerol (2-AG) is the rate-limiting step in this process. ### Main Issues 1. **Mechanism of Endocannabinoid Release**: - The traditional view holds that endocannabinoids like 2-AG are produced on demand in response to specific stimuli, but the exact molecular mechanisms remain unclear. - The paper seeks to explain how 2-AG is released from neurons and how it specifically acts on different cell types. 2. **Mechanism of Endocannabinoid Transport**: - Endocannabinoids are hydrophobic lipid molecules, making it difficult for them to be transported through traditional neurotransmitter release pathways. - The paper explores whether 2-AG is transported via extracellular microvesicles (EVs) and tests this hypothesis. 3. **Role of Regulatory Factors**: - The paper investigates the roles of protein kinase C (PKC), diacylglycerol lipase (DAGL), and ADP-ribosylation factor 6 (Arf6) in the release and transport of 2-AG. - How these regulatory factors influence the production, packaging, and release of 2-AG. ### Experimental Methods and Results - **Experimental System**: - A co-culture system of HEK293T cells expressing the eCB sensor GRAB eCB2.0 and neurons was used to observe the release and transport of 2-AG via fluorescence microscopy. - Lipid composition of EVs was analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to confirm the presence of 2-AG. - **Main Findings**: - ATP stimulation can induce neurons to release EVs containing 2-AG, while these EVs do not contain another endocannabinoid, anandamide. - Each microvesicle contains approximately 2000 molecules of 2-AG. - PKC, DAGL, and Arf6 play critical roles in the production and release of 2-AG. - Inhibition of Arf6 and eCB transport inhibitors can significantly reduce 2-AG-mediated synaptic plasticity, such as depolarization-induced suppression of inhibition (DSI). ### Conclusion The "on-demand release" model proposed in the paper, combined with mathematical analysis, provides a new framework for understanding endocannabinoid signaling. This model not only explains how 2-AG is released and transported from neurons but also reveals the important role of extracellular microvesicles in neural communication.